Obesity Clinical Trial
— FITBLUEOfficial title:
Dissemination of the Look Ahead Weight Management Treatment in the Military
| Verified date | September 2018 |
| Source | University of Tennessee |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
Purpose: This study aims to take the procedural and research-based lessons learned from a
pilot weight loss intervention (IRB # 13-02563-XP), conducted by The University of Tennessee
Health Science Center in 2013, and apply them to the current study of 204 active duty
military personnel. The pilot study translated and tailored the Look Ahead weight loss
intervention to an overweight/obese active duty U.S. Air Force population, while
accommodating the lifestyle and environment that is unique to military members and evaluate
materials and procedures used.
Rationale: Being overweight is now by far the leading medical reason for rejection in the
military. Unfortunately, the impact of weight problems on the military does not stop with
those turned away from military service. From 1998 to 2008, the Armed Forces Health
Surveillance Center reported the percent of active military members who experienced medical
encounters for overweight or obesity significantly increased. The estimated total days of
work lost from absenteeism associated with active-duty personnel who are overweight or obese
was 658,000. Using Department of Defense (DOD) estimates of average daily based, it was
estimated that overweight and obesity costs the DOD $103 million dollars in health care costs
annually. Note this estimate is for active duty personnel only. Furthermore, obesity is a
major cause for the discharge of uniformed personnel.
The current study is inspired by the successful Look Ahead trial, a behavioral science
obesity intervention treatment program that included: a collaborative approach, education,
behavioral support, and motivational interviewing. The unique nature of this weight reduction
study is significant. To our knowledge, there had not been a successful translation of a
highly efficacious obesity treatment in the military until The University of Tennessee Health
Science Center implemented a pilot version of the Fit Blue program for active duty U.S. Air
Force members in 2013. Following a successful pilot and extant results from the Look Ahead
trial, Investigators expect success during the full scale Fit Blue study.
| Status | Completed |
| Enrollment | 248 |
| Est. completion date | June 2018 |
| Est. primary completion date | March 2017 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: 1. Active duty military personnel at Joint Base San Antonio in the San Antonio, Texas area 2. BMI > 25kg/m2 3. English speaking 4. Clearance by healthcare provider for participation in study 5. >18 years of age 6. Participants have at least one year left on their duty assignment at enrollment Exclusion Criteria: 1. No access to a computer for self-monitoring in Lose It! or email feedback from counselor 2. Scheduled extended leave away from the San Antonio area in the next 13 months (i.e. planned Permanent Change of Station/Temporary Duty Assignment/deployment) 3. More than one failure of military-proctored physical fitness test on the last 12 months 4. Uncontrolled hypertension defined as Blood pressure > 140/90 5. A member of the same household is already a FitBlue participant 6. Disability or condition that would limit physical activity 7. Current use of a weight loss medication 8. History of significant kidney or liver disease 9. History of uncontrolled thyroid disease or pheochromocytoma 10. Malignancy in last 5 years 11. History of diabetes treated with a medication that could cause hypoglycemia 12. Pregnancy, child birth within the last 6 months, breastfeeding for less than 6 months postpartum, or planning to become pregnant during the study follow-up time (12 months) 13. Presence of an unstable psychiatric condition 14. Severe asthma, bronchitis, or emphysema that precludes exercise 15. History of bariatric surgery or history of significant recent weight loss ( > 10 pounds in past 3 months) 16. Other medical or behavioral factors that in the judgement of the Principal Investigator may interfere with study participation or the ability to follow the intervention protocol 17. History of cerebral, coronary, or peripheral vascular disease, uncontrolled cardiac arrhythmia, or uncontrolled congestive heart failure in past 12 months 18. Lack of access to telephone |
| Country | Name | City | State |
|---|---|---|---|
| United States | Wilford Hall Ambulatory Surgical Center/Lackland Air Force Base | San Antonio | Texas |
| Lead Sponsor | Collaborator |
|---|---|
| University of Tennessee | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), United States Air Force, University of Tennessee Health Science Center |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Percent Weight Loss (Baseline to 12 Months) | The primary data analysis will adhere to the intention-to-treat principle and in the final analysis, the participants will be categorized according to their initial randomization. Investigators will be using the baseline weight as a covariate in the final primary model where the two arms will be compared in terms of the percentage of weight loss. | 12 month intervention | |
| Secondary | The Relationship Between Attendance and Percent Weight Loss | Evaluating the impact of intervention session attendance on percent weight loss outcome, as a measure of adherence. | 12 month intervention | |
| Secondary | The Relationship Between Dietary and Physical Activity Self-monitoring Adherence and Percent Weight Loss | We will evaluate the impact of dietary and physical activity self-monitoring adherence (using Lose It website/app) on weight loss outcome. | 12 month intervention | |
| Secondary | The Relationship Between Self-weighing on Weight Loss | We will also evaluated the impact of self-weighing (using Body Trace e-scales) on weight loss outcomes. | 12 month intervention |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
| Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
| Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
| Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
| Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
| Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
| Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
| Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
| Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
| Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
| Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
| Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
| Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
| Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
| Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
| Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
| Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |